These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12546561)

  • 1. QSAR modeling of alpha-campholenic derivatives with sandalwood odor.
    Kovatcheva A; Buchbauer G; Golbraikh A; Wolschann P
    J Chem Inf Comput Sci; 2003; 43(1):259-66. PubMed ID: 12546561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR modeling of datasets with enantioselective compounds using chirality sensitive molecular descriptors.
    Kovatcheva A; Golbraikh A; Oloff S; Feng J; Zheng W; Tropsha A
    SAR QSAR Environ Res; 2005; 16(1-2):93-102. PubMed ID: 15844445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial QSAR modeling of chemical toxicants tested against Tetrahymena pyriformis.
    Zhu H; Tropsha A; Fourches D; Varnek A; Papa E; Gramatica P; Oberg T; Dao P; Cherkasov A; Tetko IV
    J Chem Inf Model; 2008 Apr; 48(4):766-84. PubMed ID: 18311912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
    Leonard JT; Roy K
    Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modeling and structure-activity relationship of podophyllotoxin and its congeners.
    Naik PK; Alam A; Malhotra A; Rizvi O
    J Biomol Screen; 2010 Jun; 15(5):528-40. PubMed ID: 20460251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D-chiral quadratic indices of the 'molecular pseudograph's atom adjacency matrix' and their application to central chirality codification: classification of ACE inhibitors and prediction of sigma-receptor antagonist activities.
    Ponce YM; Diaz HG; Zaldivar VR; Torrens F; Castro EA
    Bioorg Med Chem; 2004 Oct; 12(20):5331-42. PubMed ID: 15388160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR modeling of mono- and bis-quaternary ammonium salts that act as antagonists at neuronal nicotinic acetylcholine receptors mediating dopamine release.
    Zheng F; Bayram E; Sumithran SP; Ayers JT; Zhan CG; Schmitt JD; Dwoskin LP; Crooks PA
    Bioorg Med Chem; 2006 May; 14(9):3017-37. PubMed ID: 16431111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4D-QSAR analysis of a series of antifungal p450 inhibitors and 3D-pharmacophore comparisons as a function of alignment.
    Liu J; Pan D; Tseng Y; Hopfinger AJ
    J Chem Inf Comput Sci; 2003; 43(6):2170-9. PubMed ID: 14632469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR analyses of 3-(4-benzylpiperidin-1-yl)-N-phenylpropylamine derivatives as potent CCR5 antagonists.
    Roy K; Leonard JT
    J Chem Inf Model; 2005; 45(5):1352-68. PubMed ID: 16180912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecule kernels: a descriptor- and alignment-free quantitative structure-activity relationship approach.
    Mohr JA; Jain BJ; Obermayer K
    J Chem Inf Model; 2008 Sep; 48(9):1868-81. PubMed ID: 18767832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
    Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
    Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.
    Nandi S; Vracko M; Bagchi MC
    Chem Biol Drug Des; 2007 Nov; 70(5):424-36. PubMed ID: 17949360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
    Wang XS; Tang H; Golbraikh A; Tropsha A
    J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR of antilipid peroxidative activity of substituted benzodioxoles using chemometric tools.
    Mitra I; Roy K; Saha A
    J Comput Chem; 2009 Dec; 30(16):2712-22. PubMed ID: 19399769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
    Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of predictive QSAR models to database mining: identification and experimental validation of novel anticonvulsant compounds.
    Shen M; Béguin C; Golbraikh A; Stables JP; Kohn H; Tropsha A
    J Med Chem; 2004 Apr; 47(9):2356-64. PubMed ID: 15084134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative QSAR studies of CYP1A2 inhibitor flavonoids using 2D and 3D descriptors.
    Roy K; Roy PP
    Chem Biol Drug Des; 2008 Nov; 72(5):370-82. PubMed ID: 19012573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. kappa Nearest neighbors QSAR modeling as a variational problem: theory and applications.
    Itskowitz P; Tropsha A
    J Chem Inf Model; 2005; 45(3):777-85. PubMed ID: 15921467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.